Leptin signalling reduces the severity of cardiac dysfunction and remodelling after chronic ischaemic injury.
about
Diabetic cardiomyopathy: signaling defects and therapeutic approachesSGLT1, a novel cardiac glucose transporter, mediates increased glucose uptake in PRKAG2 cardiomyopathyCardiac-specific leptin receptor deletion exacerbates ischaemic heart failure in mice.Anti-inflammatory and cardioprotective effects of tadalafil in diabetic micePressure mediated hypertrophy and mechanical stretch up-regulate expression of the long form of leptin receptor (ob-Rb) in rat cardiac myocytes.A micro-ribonucleic acid signature associated with recovery from assist device support in 2 groups of patients with severe heart failureAdipokines and the Right Ventricle: The MESA-RV Study.The Association of Serum Leptin with Mortality in Older Adults.Long-Lived αMUPA Mice Show Attenuation of Cardiac Aging and Leptin-Dependent Cardioprotection.Leptin levels predict survival in pulmonary arterial hypertension.Angiotensin-converting enzyme inhibition and food restriction in diabetic mice do not correct the increased sensitivity for ischemia-reperfusion injury.Chronic intermittent hypoxia exposure improves left ventricular contractility in transgenic mice with heart failure.Cardiomyocyte-specific deletion of leptin receptors causes lethal heart failure in Cre-recombinase-mediated cardiotoxicity.Importance of leptin signaling and signal transducer and activator of transcription-3 activation in mediating the cardiac hypertrophy associated with obesityPlasma leptin levels and incidence of heart failure, cardiovascular disease, and total mortality in elderly individualsSignalling mechanisms underlying the metabolic and other effects of adipokines on the heart.Type 2 diabetes, mitochondrial biology and the heart.Investigation into the optimal surgical conditions for coronary artery ligation for establishing a myocardial infarction model in mice.Leptin attenuates cardiac apoptosis after chronic ischaemic injurySGLT1 is a novel cardiac glucose transporter that is perturbed in disease states.Relation of serum leptin with cardiac mass and left atrial dimension in individuals >70 years of age.Enhanced hypertrophy in ob/ob mice due to an impairment in expression of atrial natriuretic peptide.Chronic intermittent hypoxia increases left ventricular contractility in C57BL/6J mice.Leptin signaling is required for augmented therapeutic properties of mesenchymal stem cells conferred by hypoxia preconditioning.Extracellular superoxide dismutase regulates cardiac function and fibrosis.Leptin signaling in the failing and mechanically unloaded human heart.Diabetic Cardiomyopathy: Mechanisms and Therapeutic Targets.Understanding STAT3 signaling in cardiac ischemia.The cellular specificity of leptin-mediated actions in the infarcted heart.Inhibition of cardiac leptin expression after infarction reduces subsequent dysfunctionLeptin regulates MMP-2, TIMP-1 and collagen synthesis via p38 MAPK in HL-1 murine cardiomyocytes.Beneficial effects of leptin treatment in a setting of cardiac dysfunction induced by transverse aortic constriction in mouse.
P2860
Q28395852-7AC4E74A-A942-4F67-A87D-F8072FC00F9BQ34101200-7A4290F3-1BBB-4E80-B20E-BDDC3BAA1463Q34410318-8A8709EE-0AC9-4E7A-BE49-ECC280C5E29AQ34428464-5850E637-6952-4470-B204-51DDA1CA93DCQ34523615-F6F0DF6F-AF51-48CB-AC60-92C1A45FC881Q35580664-1EB6FD81-3665-4097-A7A1-B0B3C9CBD9B7Q35766863-00C4AB6C-8EAD-45CF-BE05-042E13D5B516Q35810090-370720D2-82CE-46DE-BF2E-99D90C290E17Q35870187-346CF40C-3577-477E-859A-27C2BA28C330Q36108060-FC3EBE56-D454-46A7-A2FB-0B36003F55E6Q36239967-EFB98818-5A54-4C0F-A2C8-CBF68850C551Q36320864-F5883F1F-B2E6-46FF-9BBF-FD67C88CE802Q36494881-18BEA062-7F81-4CC5-A136-200F49BCFF54Q37028671-41C6A960-611D-4641-9399-93E607F13343Q37139425-79A6410C-5AA3-43C4-ADC6-5E6AB4908F08Q37161801-82C40A40-9317-4C7D-B749-6243BBC7048EQ37195072-0C647A6B-F648-4B76-9523-4EE1190293DEQ37207226-B4D6D500-27D2-4191-9B8B-55B4C865321CQ37240941-57FA349B-7A9D-447C-9735-40C1413AA598Q37341063-850DFCF2-0F25-4495-A96F-868D53E094A9Q37350566-F06F27A2-88AE-4282-9DDE-FBE3620CF11CQ37354583-C9070376-F00E-4DC0-9AE6-4EBB7C6540CDQ37372426-3DA1C42A-54C4-4FF1-A78D-409866C20184Q37394751-79776778-3B85-489E-BD59-B137F5313826Q37415318-04811BDC-9F46-4D7C-B067-5E1F459FEF62Q37428292-52962ED7-26CA-46F9-AE06-0A7F6455842FQ37832957-D39AB710-650F-48BA-BB7C-11E288D492A7Q38790211-1573ABF8-0687-4BFC-8188-0AE92A74D896Q42542632-E80B2A2C-B0BC-4901-8808-1BE33F22EDE7Q42697262-C0DF1576-85B1-4368-9D09-2D01F7B4DF91Q42947348-71CE17DC-A06B-451A-BC69-396EC858F73AQ48325152-9157E006-E630-4D73-929A-E537E23372B5
P2860
Leptin signalling reduces the severity of cardiac dysfunction and remodelling after chronic ischaemic injury.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Leptin signalling reduces the ...... fter chronic ischaemic injury.
@en
type
label
Leptin signalling reduces the ...... fter chronic ischaemic injury.
@en
prefLabel
Leptin signalling reduces the ...... fter chronic ischaemic injury.
@en
P2093
P2860
P356
P1476
Leptin signalling reduces the ...... after chronic ischaemic injury
@en
P2093
Charles F McTiernan
Christopher P O'Donnell
Jennifer J Rager
Kenneth R McGaffin
Lia C Romano
Michael A Mathier
Robert M O'Doherty
P2860
P356
10.1093/CVR/CVM023
P577
2007-09-20T00:00:00Z